Theravance Biopharma TBPH Income Taxes Paid, Net
Income Taxes Paid, Net at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's income taxes paid, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's income taxes paid, net?
- Theravance Biopharma (TBPH) reported income taxes paid, net of -$351K in Q1 2026.
- How has Theravance Biopharma's income taxes paid, net changed year-over-year?
- Theravance Biopharma's income taxes paid, net decreased by 8875.0% year-over-year, from $4K to -$351K.
- What is the long-term trend for Theravance Biopharma's income taxes paid, net?
- Over 2 years (2023 to 2025), Theravance Biopharma's income taxes paid, net has grown at a 3308.6% compound annual growth rate (CAGR), from $24K to $27.88M.
- What does income taxes paid, net mean?
- This represents the actual cash outflow for income taxes during the period, net of any refunds received. Unlike the income tax expense reported on the income statement, this figure reflects the timing of actual tax payments to government authorities. It is a key indicator of the company's effective cash tax rate and its ability to manage tax liabilities.